State of Wisconsin Investment Board’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $896K | Buy |
177,009
+4,894
| +3% | +$24.8K | ﹤0.01% | 1618 |
|
|
2025
Q1 | $910K | Buy |
172,115
+1,460
| +0.9% | +$7.72K | ﹤0.01% | 1520 |
|
|
2024
Q4 | $1.15M | Buy |
170,655
+78,326
| +85% | +$529K | ﹤0.01% | 1463 |
|
|
2024
Q3 | $608K | Sell |
92,329
-8,225
| -8% | -$54.2K | ﹤0.01% | 1778 |
|
|
2024
Q2 | $754K | Sell |
100,554
-4,572
| -4% | -$34.3K | ﹤0.01% | 1637 |
|
|
2024
Q1 | $1.05M | Sell |
105,126
-2,504
| -2% | -$25K | ﹤0.01% | 1413 |
|
|
2023
Q4 | $1.06M | Sell |
107,630
-2,169
| -2% | -$21.4K | ﹤0.01% | 1372 |
|
|
2023
Q3 | $840K | Sell |
109,799
-2,485
| -2% | -$19K | ﹤0.01% | 1456 |
|
|
2023
Q2 | $839K | Buy |
112,284
+61,973
| +123% | +$463K | ﹤0.01% | 1527 |
|
|
2023
Q1 | $336K | Buy |
50,311
+4,130
| +9% | +$27.5K | ﹤0.01% | 2035 |
|
|
2022
Q4 | $356K | Sell |
46,181
-26,342
| -36% | -$203K | ﹤0.01% | 2032 |
|
|
2022
Q3 | $772K | Buy |
72,523
+27,879
| +62% | +$297K | ﹤0.01% | 1689 |
|
|
2022
Q2 | $363K | Sell |
44,644
-107,656
| -71% | -$875K | ﹤0.01% | 2236 |
|
|
2022
Q1 | $1.09M | Hold |
152,300
| – | – | ﹤0.01% | 1623 |
|
|
2021
Q4 | $2.61M | Buy |
152,300
+125,000
| +458% | +$2.14M | 0.01% | 1204 |
|
|
2021
Q3 | $628K | Hold |
27,300
| – | – | ﹤0.01% | 1611 |
|
|
2021
Q2 | $996K | Buy |
+27,300
| New | +$996K | ﹤0.01% | 1454 |
|